Hypermethylation of NPTX2 in pancreatic cancer tissue may constitute a molecular diagnostic marker [45], and NPTX2 methylation levels in tumoral tissue have been associated with poor survival in PDAC patients [20]. The gene discussed is NPTX2; the disease is pancreatic neoplasm.